Stopping cancer in its tracks

Israel’s Metabomed is developing treatments using small molecules that target and inhibit metabolic enzymes vital for cancer cells’ survival.  It currently has four pipeline programs. Metabomed has just raised a further $12.5 million of funds to help it prepare for clinical trials.,7340,L-3776158,00.html

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *